Skip to main content
TipRanks
Go Ultimate75% OFF

Fredrik Lehmann Insider Profile

4 Followers

Fredrik Lehmann, Head of Research & Development at Oncopeptides AB, holds 32.70K shares in Oncopeptides AB (Ticker: SE:ONCO).

Fredrik Lehmann's Trading History

ONCO
Oncopeptides AB
Feb 24, 2022Head of Research & DevelopmentUninformative Sell1.29Kkr57.88K
SE:ONCO
Insider Shares: 32.70K (4.34%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 24, 2022Uninformative Sellkr1.29K11,700kr0.11――
Nov 24, 2021Informative Buykr57.55K5,000kr11.51+45.80%―
Sep 14, 2021Informative Buykr42.76K1,000kr42.76-23.20%―
May 28, 2021Informative Buykr200.00K2,000kr100.00-91.40%―
Jan 15, 2021Informative Sellkr772.23K4,652kr166.00+39.10%―

You May Also Like

Fredrik Lehmann insider profile FAQ

What is the percentage of profitable transactions made by Fredrik Lehmann?
The percentage of profitable transactions made by Fredrik Lehmann is 82%.
What is the average return per transaction made by Fredrik Lehmann?
The average return per transaction made by Fredrik Lehmann is 44.90%.
What stocks does Fredrik Lehmann hold?
Fredrik Lehmann holds: SE:ONCO stocks.
What was Fredrik Lehmann’s latest transaction?
Fredrik Lehmann’s latest transaction was an Uninformative Sell of kr1.29K.
What was Fredrik Lehmann's most profitable transaction?
Fredrik Lehmann’s most profitable transaction was an Informative Buy of SE:ONCO stock on July 14, 2017. The return on the trade was 216.40%.
What is Fredrik Lehmann's role in Oncopeptides AB?
Fredrik Lehmann's role in Oncopeptides AB is Head of Research & Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.